Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 55 results.

Thumbnail for Reduction in Thyroid Volume in Patients With Chronic Myeloid Leukemia After Imatinib Treatment: A Prospective Cohort Study

CML - 029

Reduction in Thyroid Volume in Patients With Chronic Myeloid Leukemia After Imatinib Treatment: A Prospective Cohort Study

Ibrahim Ahmed

Poster Presenter: Ibrahim Ahmed

Thumbnail for Role of MicroRNA as a Key Epigenetic Regulator in Promoting Nuclear Reprogramming in an Adult Egyptian Chronic Myeloid Leukemia Patient

CML - 053

Role of MicroRNA as a Key Epigenetic Regulator in Promoting Nuclear Reprogramming in an Adult Egyptian Chronic Myeloid Leukemia Patient

Haydi Mohamed

Poster Presenter: Haydi Mohamed

CML - 090

Real-World Data on Clinical Profile, Treatment Strategies, and Feto-Maternal Outcomes of Pregnancies Among Patients With Chronic Myeloid Leukemia in a Resource-Constrained Setting: A 5-Year Single-Center Retrospective Cohort Study

Caryn Louise Gutierrez

Poster Presenter: Caryn Louise Gutierrez

Thumbnail for Efficacy and Safety of a Pakistan-Manufactured Generic Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Multicenter Phase 4 Study

CML - 1023

Efficacy and Safety of a Pakistan-Manufactured Generic Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Multicenter Phase 4 Study

Zeba Aziz

Poster Presenter: Zeba Aziz

Thumbnail for ASC4FIRST Week (Wk) 144 Analysis: Continued Superior Efficacy and Favorable Safety of Asciminib (ASC) vs Investigator-Selected Tyrosine Kinase Inhibitors (IS-TKIs) in Newly Diagnosed (ND) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

CML - 1050

ASC4FIRST Week (Wk) 144 Analysis: Continued Superior Efficacy and Favorable Safety of Asciminib (ASC) vs Investigator-Selected Tyrosine Kinase Inhibitors (IS-TKIs) in Newly Diagnosed (ND) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Ghayas Issa

Poster Presenter: Ghayas Issa

Thumbnail for Genetic Mutations Detected in Adult Patients Diagnosed With Chronic Myeloid Leukemia (CML): 24 Years of Experience in a Public Hospital in Guatemala

CML - 1071

Genetic Mutations Detected in Adult Patients Diagnosed With Chronic Myeloid Leukemia (CML): 24 Years of Experience in a Public Hospital in Guatemala

Ann Margareth Wagner-Nitsch

Poster Presenter: Ann Margareth Wagner-Nitsch

Thumbnail for Digital PCR versus qPCR for BCR::ABL1 Monitoring and Treatment-Free Remission Prediction in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

CML - 1127

Digital PCR versus qPCR for BCR::ABL1 Monitoring and Treatment-Free Remission Prediction in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

Amal Paul

Poster Presenter: Amal Paul

Thumbnail for Sequential Enumeration of CD26+ Leukemic Stem Cells and Its Correlation With BCR::ABL1 Transcript Levels in Chronic Myeloid Leukemia at Diagnosis and During Tyrosine Kinase Inhibitor Therapy

CML - 1129

Sequential Enumeration of CD26+ Leukemic Stem Cells and Its Correlation With BCR::ABL1 Transcript Levels in Chronic Myeloid Leukemia at Diagnosis and During Tyrosine Kinase Inhibitor Therapy

Praveen Sharma

Poster Presenter: Praveen Sharma

Thumbnail for Efficacy and Safety of Asciminib Dose Escalation in Patients with Chronic Myeloid Leukemia (CML) without Optimal Response to the Standard Dose

CML - 1134

Efficacy and Safety of Asciminib Dose Escalation in Patients with Chronic Myeloid Leukemia (CML) without Optimal Response to the Standard Dose

Elza Lomaia

Poster Presenter: Elza Lomaia

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.